Sanguina
FDA Clearance for At-Home Hemoglobin Testing
Sanguina has reached a significant regulatory milestone with the US FDA clearance of its hemoglobin test kit. This in vitro diagnostic device provides a prescription-based, point-of-care solution for monitoring blood health. This clearance validates Sanguina’s commitment to providing accessible, high-quality diagnostic tools that empower patients and providers to manage anemia and other blood-related conditions with greater ease.
